Zurich Cantonal Bank
AMRX icon

Zurich Cantonal Bank’s Amneal Pharmaceuticals AMRX Stock Holding History

Zurich Cantonal Bank’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-68,137
Closed -$859K – 2601
2025
Q4 		$859K Buy
+68,137
New +$780K ﹤0.01% 1430

Other funds holding AMRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Zurich Cantonal Bank's AMRX Position: Q1 2026 in Review

Zurich Cantonal Bank opened a new position in Amneal Pharmaceuticals (AMRX) in Q1 2026: 100,944 shares worth $1.25M. The stake represents ﹤0.01% of the portfolio and ranks #1300 among its holdings. This is a return to the name: Zurich Cantonal Bank previously reported a position in AMRX as recently as Q3 2025.

Zurich Cantonal Bank first reported a position in AMRX in Q3 2018 and has held it in 28 quarters since. 316 funds tracked by Wall St. Rank hold AMRX as of Q1 2026.

  • Zurich Cantonal Bank held 100,944 shares of Amneal Pharmaceuticals worth $1.25M as of Q1 2026.
  • Amneal Pharmaceuticals was a new Zurich Cantonal Bank position in Q1 2026.
  • Amneal Pharmaceuticals made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q1 2026, its #1300 holding.
  • Zurich Cantonal Bank first reported a position in Amneal Pharmaceuticals in Q3 2018 and has held it in 28 quarters since.
  • 316 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.